| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Relmada Therapeutics, Inc. (RLMD) has 7 insiders with recent SEC Form 4 filings, including 35 buys and 0 sells. RLMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.30M | $9.52M | - | |
| COO | 828.0K | $6.06M | - | |
| Other | 828.0K | $6.06M | - | |
| CFO | 800.0K | $5.86M | - | |
| Dir | 164.0K | $1.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2018 | Kelly Paul Edward53 | Director | Buy | 5,000 | $1.21 | $6,065.00 | +1.3% | |
| Oct 12, 2018 | Kelly Paul Edward53 | Director | Buy | 150,000 | $0.90 | $135,000.00 | +1,500% | |
| Dec 31, 2015 | Agharkar Shreeram | Director | Buy | 400 | $2.50 | $1,000.00 | +7.5% | |
| Dec 16, 2015 | Agharkar Shreeram | Director | Buy | 1,100 | $3.43 | $3,775.00 | +11.6% | |
| Dec 15, 2015 | Traversa Sergio55 | Chief Executive Officer | Buy | 18,970 | $3.05 | $57,792.11 | +0.6% | |
| Dec 15, 2015 | Shenouda Maged | Director | Buy | 3,000 | $2.99 | $8,957.59 | +29.3% | |
| Dec 15, 2015 | Seth Sandesh | Director | Buy | 9,500 | $3.19 | $30,313.00 | +1.6% | |
| Dec 14, 2015 | Seth Sandesh | Director | Buy | 10,500 | $2.93 | $30,728.40 | +1.4% | |
| Dec 14, 2015 | Shenouda Maged | Director | Buy | 2,000 | $2.89 | $5,780.00 | New | |
| Dec 14, 2015 | Casamento Charles J71 | Director | Buy | 4,200 | $2.97 | $12,464.00 | +35.6% |